ProKidney Corp
NASDAQ:PROK
Income Statement
Earnings Waterfall
ProKidney Corp
Income Statement
ProKidney Corp
| Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||
| Interest Expense |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
+303%
|
1
+72%
|
1
+41%
|
|
| Operating Income | |||||||||||||||||
| Operating Expenses |
(55)
|
(110)
|
(118)
|
(136)
|
(153)
|
(127)
|
(147)
|
(158)
|
(152)
|
(151)
|
(154)
|
(156)
|
(178)
|
(185)
|
(182)
|
(172)
|
|
| Selling, General & Administrative |
(9)
|
(45)
|
(53)
|
(65)
|
(71)
|
(48)
|
(53)
|
(52)
|
(45)
|
(42)
|
(43)
|
(46)
|
(51)
|
(58)
|
(58)
|
(52)
|
|
| Research & Development |
(46)
|
(65)
|
(65)
|
(72)
|
(82)
|
(79)
|
(94)
|
(105)
|
(107)
|
(108)
|
(111)
|
(110)
|
(128)
|
(128)
|
(124)
|
(120)
|
|
| Operating Income |
(55)
N/A
|
(110)
-100%
|
(118)
-7%
|
(136)
-16%
|
(153)
-12%
|
(127)
+17%
|
(147)
-15%
|
(158)
-8%
|
(152)
+4%
|
(151)
+1%
|
(154)
-2%
|
(156)
-2%
|
(178)
-14%
|
(185)
-4%
|
(182)
+2%
|
(171)
+6%
|
|
| Pre-Tax Income | |||||||||||||||||
| Interest Income Expense |
0
|
(0)
|
(0)
|
1
|
6
|
11
|
17
|
21
|
22
|
22
|
20
|
20
|
20
|
19
|
18
|
16
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(5)
|
0
|
0
|
0
|
|
| Pre-Tax Income |
(55)
N/A
|
(110)
-100%
|
(118)
-7%
|
(135)
-14%
|
(147)
-9%
|
(116)
+21%
|
(129)
-11%
|
(136)
-5%
|
(129)
+5%
|
(129)
+0%
|
(134)
-4%
|
(136)
-2%
|
(164)
-20%
|
(166)
-1%
|
(164)
+1%
|
(156)
+5%
|
|
| Net Income | |||||||||||||||||
| Tax Provision |
(0)
|
(1)
|
(2)
|
(2)
|
(1)
|
(1)
|
(1)
|
(2)
|
(6)
|
(5)
|
(4)
|
(0)
|
1
|
0
|
(1)
|
(4)
|
|
| Income from Continuing Operations |
(55)
|
(111)
|
(120)
|
(137)
|
(148)
|
(118)
|
(130)
|
(138)
|
(135)
|
(134)
|
(138)
|
(137)
|
(163)
|
(166)
|
(164)
|
(159)
|
|
| Income to Minority Interest |
0
|
0
|
0
|
22
|
40
|
67
|
93
|
102
|
100
|
99
|
99
|
91
|
102
|
98
|
92
|
88
|
|
| Net Income (Common) |
(55)
N/A
|
(111)
-101%
|
(120)
-8%
|
(115)
+4%
|
(108)
+6%
|
(50)
+54%
|
(37)
+26%
|
(36)
+3%
|
(35)
+2%
|
(35)
+0%
|
(39)
-10%
|
(46)
-18%
|
(61)
-34%
|
(68)
-12%
|
(72)
-6%
|
(71)
+2%
|
|
| EPS (Diluted) |
-0.9
N/A
|
-1.81
-101%
|
-1.96
-8%
|
-1.87
+5%
|
-1.76
+6%
|
-0.82
+53%
|
-0.57
+30%
|
-0.59
-4%
|
-0.57
+3%
|
-0.57
N/A
|
-0.5
+12%
|
-0.36
+28%
|
-0.62
-72%
|
-0.53
+15%
|
-0.56
-6%
|
-0.54
+4%
|
|